"The Super Generics industry has enjoyed a remarkable run over the past two decades. The vast healthcare cost-saving potential of these therapies has accelerated their adoption and proven the immense potential that generics have to reach wider segments. The problems arrive:

While the generics market is highly attractive, the increasing competition in this domain has decreased the profit margins of each player and has pushed the developers to actively look for alternate opportunities in this segment."

Leave a Reply